Form D · Other Technology

Ember LifeSciences, Inc.

Westlake Village, CA · CIK 0002110315

Offering snapshot reported Aug 20, 2026 · SEC filing

Reported sold: $32.2M
Investors reported: 50
Minimum accepted: $1
First sale: Jun 16, 2025

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$20,941,497 → $32,166,448
Reported investors38 → 50

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Aug 20, 2026	Amendment	$32,166,448	$11,224,951vs Mar 3, 2026	50	SEC filing
Mar 3, 2026	Initial	$20,941,497	No comparison	38	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-575172

$50mil in new Series A authorized alongside conversions of $55mil of prior raises SAFEs. Total amount sold includes new Series A capital only (of the $50mil authorized) that has closed as of August 20, 2026.

0N/A - No finders' fees, nor commissions.

Source: Form D, filed Aug 20, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Clayton Marie Alexander	Director, Executive
Brian Bejarano	Executive
James De Naut	Director
Ann Hyllengren	Executive
Michael Kaufmann	Director
Timothy White	Director

Issuer details

Industry: Other Technology (See others in industry)

Address:

31416 Agoura Rd
Westlake Village, CA, 91361